Annual risk of hepatitis E virus infection and seroreversion: Insights from a serological cohort in Sitakunda, BangladeshOriginal Paper Published on 2024-03-182024-09-05 Journal: Epidemiology and Infection [Category] update2024, [키워드] antibody waning hepatitis E virus risk of infection serology [DOI] 10.1017/S0950268824000438 PMC 바로가기 [Article Type] Original Paper
SARS-CoV-2 Exposition und Seroprävalenz von SARS-CoV-2-Antikörpern bei Medizinstudierenden in der ersten Phase der Pandemie, 2020–2021article Published on 2024-01-052024-09-05 Journal: Gesundheitswesen (Bundesverband der Ärzte des Öffe [Category] update2024, [키워드] COVID-19 health care workers Infektionsrisiko Medizinisches Personal risk of infection ungeimpft unvaccinated [DOI] 10.1055/a-2183-7279 PMC 바로가기 [Article Type] article
Glycemic control predicts SARS-CoV-2 prognosis in diabetic subjectsOriginal Article Published on 2023-03-202024-09-05 Journal: Acta Diabetologica [Category] update2024, [키워드] COVID-19 Diabetes Mellitus Duration of diabetes HbA1c risk of infection SARS-CoV-2 [DOI] 10.1007/s00592-023-02073-4 PMC 바로가기 [Article Type] Original Article
Acute effects of concurrent muscle power and sport-specific endurance exercises on markers of immunological stress response and measures of muscular fitness in highly trained youth male athletesarticle Published on 2023-01-102024-09-05 Journal: European Journal of Applied Physiology [Category] update2024, [키워드] adolescents Combat sports concurrent training leucocytosis lymphocytosis risk of infection White blood cells [DOI] 10.1007/s00421-022-05126-8 PMC 바로가기 [Article Type] article
The vulnerability of maintenance dialysis patients with COVID-19: mortality and risk factors from a developing countryObservational Study Published on 2022-12-012022-10-04 Journal: Annals of Medicine [Category] 임상, [키워드] age Blood Group Characteristics Clinical features collected data complications country COVID-19 death demographics diabetes dialysis epidemiological Factor General population Haemodialysis hospitalisation ICU admission implementation incidence incidence of COVID-19 increased risk independent risk factor infected patient Infection infection control intensive care intubation Male sex measure Measures Mortality mortality rate mortality rate; multivariable logistic regression old age outcomes Patient patients Peritoneal dialysis positive Predictive reduce required retrospective risk risk factor risk of infection significantly significantly increased smoking study period tested therapy Vascular venous catheter was used West Bank [DOI] 10.1080/07853890.2022.2075914 PMC 바로가기 [Article Type] Observational Study
[Prostate cancer, androgen deprivation, and risk of COVID-19 infection : A systematic review and meta-analysis]Meta-Analysis Published on 2022-12-012023-07-10 Journal: Progrès en urologie : journal de l'Association fra [Category] COVID19(2023년), [키워드] Androgen deprivation therapy Cancer de prostate COVID-19 Déprivation androgénique hospitalisation Hospitalization Mortalité Mortality Prostate cancer risk of infection Risque d’infection. [DOI] 10.1016/j.purol.2022.09.005 PMC 바로가기 [Article Type] Meta-Analysis
Protection against Omicron from Vaccination and Previous Infection in a Prison SystemArticle Published on 2022-11-102022-11-16 Journal: The New England Journal of Medicine [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval acute respiratory syndrome Analysis B.1.1.529 B.1.617.2 booster collected Combination coronavirus Cox model dose doses effective Effectiveness estimate evaluate evaluated hazard ratio high-risk population Infection mRNA mRNA vaccination mRNA vaccine offered omicron Omicron variant prison protection ranged retrospective cohort risk of infection SARS-CoV-2 significantly more stratified System vaccination vaccine dose vaccine doses variant were used [DOI] 10.1056/NEJMoa2207082 PMC 바로가기
Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosisArticle Published on 2022-11-012022-11-16 Journal: Journal of hepatology [Category] SARS, 변종, [키워드] 95% CI appear B.1.1.529 B.1.617.2 BNT BNT162b2 BNT162b2 mRNA booster booster dose chronic liver disease cirrhosis compensated Control control group COVD-19 COVID-19 COVID-19 in patient COVID-19 vaccines COVID-19-related death Critical dose doses General population greater hepatic decompensation hyporesponsiveness immune dysregulation liver magnitude moderate Moderate COVID-19 Moderna mRNA-1273 vaccine mRNA vaccine mRNA-1273 outcome overcome participant Patient Pfizer predominant receipt reduction in retrospective cohort study risk of infection Support symptomatic the vaccine Vaccine Vaccines variants veteran with COVID-19 [DOI] 10.1016/j.jhep.2022.07.036 PMC 바로가기
Reliability and clinical correlations of semi-quantitative lung ultrasound on BLUE points in COVID-19 mechanically ventilated patients: The ‘BLUE-LUSS’-A feasibility clinical studyArticle Published on 2022-10-142022-11-16 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 치료기술, [키워드] clinical study correlated correlation COVID-19 COVID-19 pandemic Critically ill Critically ill patient critically ill patients diagnostic feasibility ICUs independent indicated information intensive care intensive care unit Intervention lung Lung pathology mechanically ventilated P/F P/F ratio positive reduce Region reliability risk of infection RT-PCR SARS-CoV2 semi-quantitative significantly single-center the patient Treatment university Variability ventilated patient was performed were recorded [DOI] 10.1371/journal.pone.0276213 PMC 바로가기
Magnitude and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission: A Longitudinal Cohort StudyArticle Published on 2022-10-032022-11-15 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute respiratory syndrome confidence interval Contact coronavirus coronavirus 2 cumulative determinant Epidemiology evaluated household household contact household contacts household transmission incidence increased risk increasingly individual Infection infectious viral shedding. Intervention longitudinal magnitude nasal occurred populations Primary outcome reduce respiratory risk of infection RNA SARS-CoV-2 SARS-COV-2 infection specimen Symptom symptom onset symptomatic symptomatic SARS-CoV-2 infection Transmission transmission of SARS-CoV-2 vaccination viral shedding [DOI] 10.1093/cid/ciac545 PMC 바로가기